1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow E7777 fusion protein: new trials by email Literature Review of E7777 fusion protein trials Research Report on E7777 fusion protein
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma E7777 - Peripheral T-Cell Lymphoma | Phase 3 | Withdrawn | Eisai Inc. | 2011-03-01 | 2013-11-18 |
Lymphoma, T-Cell, Peripheral (1)
Eisai Inc. (1)
United States (1)
Chean Eng Ooi (1)